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Abstract
Background: Meta-analyses show collaborative care models (CCMs) with nurse care management are effective for
improving primary care for depression. This study aimed to develop CCM approaches that could be sustained and
spread within Veterans Affairs (VA). Evidence-based quality improvement (EBQI) uses QI approaches within a
research/clinical partnership to redesign care. The study used EBQI methods for CCM redesign, tested the
effectiveness of the locally adapted model as implemented, and assessed the contextual factors shaping
intervention effectiveness.
Methods: The study intervention is EBQI as applied to CCM implementation. The study uses a cluster randomized
design as a formative evaluation tool to test and improve the effectiveness of the redesign process, with seven
intervention and three non-intervention VA primary care practices in five different states. The primary study
outcome is patient antidepressant use. The context evaluation is descriptive and uses subgroup analysis. The
primary context evaluation measure is naturalistic primary care clinician (PCC) predilection to adopt CCM.
For the randomized evaluation, trained telephone research interviewers enrolled consecutive primary care patients
with major depression in the evaluation, referred enrolled patients in intervention practices to the implemented
CCM, and re-surveyed at seven months.
Results: Interviewers enrolled 288 CCM site and 258 non-CCM site patients. Enrolled intervention site patients were
more likely to receive appropriate antidepressant care (66% versus 43%, p = 0.01), but showed no significant
difference in symptom improvement compared to usual care. In terms of context, only 40% of enrolled patients
received complete care management per protocol. PCC predilection to adopt CCM had substantial effects on
patient participation, with patients belonging to early adopter clinicians completing adequate care manager follow-
up significantly more often than patients of clinicians with low predilection to adopt CCM (74% versus 48%%, p =
0.003).
Conclusions: Depression CCM designed and implemented by primary care practices using EBQI improved
antidepressant initiation. Combining QI methods with a randomized evaluation proved challenging, but enabled
new insights into the process of translating research-based CCM into practice. Future research on the effects of
PCC attitudes and skills on CCM results, as well as on enhancing the link between improved antidepressant use
and symptom outcomes, is needed.
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Despite efficacious therapies, depression remains a lead-
ing cause of disability [1-3]. Most depression is detected
in primary care, yet rates of appropriate treatment for
detected patients remain low. There is ample rando-
mized trial evidence that collaborative care management
(CCM) for depression is an effective [4-6] and cost-
effective [7] approach to improving treatment and out-
comes for these patients. In CCM, a care manager sup-
ports primary care clinicians (PCCs) in assessing and
treating depression symptoms, often with active involve-
ment of collaborating mental health specialists. Care
managers typically carry out a comprehensive initial
assessment followed by a series of subsequent contacts
focusing on treatment adherence and patient education
and/or activation. Use of CCM, however, is not yet
widespread in routine primary care settings. This study
aimed to use a cluster-randomized design to formatively
evaluate the success of evidence-based quality improve-
ment (EBQI) methods in implementing effective CCM
as part of routine Veteran Affairs (VA) care. Problems
detected through our rigorous evaluation could then be
used to support higher quality model development for
sustaining and spreading CCM in VA primary care
practices nationally. The study’s major goals were thus:
to learn about the process of implementing research in
practice, including effects of context; to test the effec-
tiveness of EBQI for adapting research-based CCM
while maintaining its effectiveness; and to provide infor-
mation for improving the implemented model.
Implementation of CCM as part of routine primary
care requires system redesign. EBQI is a redesign
method that supports clinical managers in making use
of prior evidence on effective care models while taking
account of local context [8-10]. For this study, VA
regional leaders and participating local sites adapted
CCM to VA system and site conditions using EBQI
[11]. We term the locally adapted CCM model EBQI-
CCM. The study used a cluster-randomized design to
evaluate seven EBQI-CCM primary care practices versus
three equivalent practices without EBQI-CCM.
Theory suggests that durable organizational change of
the kind required by CCM is most likely when stake-
holders are involved in design and implementation
[12,13]. Yet classical continuous quality improvement
(CQI) for depression, which maximizes participation,
does not improve outcomes [14,15]. EBQI, a more struc-
tured form of CQI that engages leaders and QI teams in
setting depression care priorities and understanding the
evidence base and focuses teams on adapting existing
CCM evidence and tools, has been more successful
[8,16-18]. This study built on previous EBQI studies by
adding external technical expert support from the
research team to leverage the efforts of QI teams [19].
CCM can be considered a practice innovation.
Research shows that early adopters of innovations may
be different from those who lag in using the innovation
[ 2 0 ] .W eh y p o t h e s i z e dt h a tC C M ,w h i c hd e p e n d so n
PCC participation, might yield different outcomes for
patients of early adopter clinicians compared to patients
of clinicians who demonstrated less use of the model.
We found no prior CCM studies on this topic. Because
this study tested a CCM model that was implemented
as routine care prior to and during the randomized trial
reported here, we were able to classify clinicians in
terms of predilection to adopt CCM based on their
observed model participation outside of the randomized
trial. We then assessed CCM outcomes for our enrolled
patient sample as a function of their PCC’s predilection
to adopt the model.
In this paper, we evaluate implementation by asking
the intent to treat question: did depressed EBQI-CCM
practice patients enrolled in the randomized evaluation
and referred to CCM have better care than depressed
patients at practices not implementing CCM? We also
asked the contextual subgroup question: do EBQI-CCM
site patients of early adopter clinicians experience differ-
ent CCM participation outcomes than those of clinicians
with a low predilection to adopt CCM? Because our
purpose was to study and formatively evaluate the
implementation of a well-researched technology [5], our
grant proposal powered the study on a process of care
change (antidepressant use). We also assessed pre-post
depression symptom outcome data on all patients
referred to care management as part of EBQI. This data
is documented elsewhere [11], and is used in this paper
to gain insight into differences between naturalistically-
referred patients (representing true routine care use of
CCM in the sites outside of research) and study enrolled
patients.
Methods
This study evaluated EBQI-CCM implementation
through a cluster-randomized trial. The EBQI process
occurred in seven randomly allocated group practices in
three VA multi-state administrative regions; three addi-
tional practices (one in each region) were simulta-
neously selected to serve as comparison sites in the
subsequent cluster randomized evaluation reported here.
Primary care providers began referring their patients to
EBQI-CCM through VA’s usual computer-based consult
system a year prior to any patient enrollment in the ran-
d o m i z e de v a l u a t i o na sp a r to ft h eo n g o i n gT I D E S
(Translating Initiatives in Depression into Effective
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the EBQI process and QI outcomes is available [11].
Setting
Researchers formed partnerships with three volunteer
Veterans Health Administration regions between 2001
and 2002 to foster a CCM implementation QI project
(TIDES). Participating regions spanned 19 states in the
Midwest and South. Regional directors agreed to engage
their mental health, primary care, QI, and nursing lea-
dership in EBQI teams for improving depression care,
and to provide release time to enable team members to
participate. Each region agreed to hire a care manager
for depression. Researchers provided dollars totaling the
e q u i v a l e n to fo n eh a l f t i m en u r s ec a r em a n a g e rf o r2 1
months to each region.
Prior to initiation of EBQI, each regional administrator
agreed to identify three primary care practices of similar
size, availability of mental health personnel, and patient
population profiles for participation in the study. Study
practices mirrored staffing characteristics of small to
medium-sized non-academic practices nationally in VA.
As described elsewhere, however, baseline levels of par-
ticipation in care for depression in primary care varied
[21].
Randomization
In 2002, the study statistician randomly assigned one
practice per region as control practices, and the remain-
ing two practices per region to EBQI-CCM. One of the
six EBQI-CCM sites selected by regional administrators
was a single administrative entity but composed of two
geographically separated practices with different staffing.
We therefore analyzed it as two separate practices for a
total of seven EBQI-CCM sites.
Human Subjects Protection
All study procedures for the QI process and for the ran-
domized evaluation were approved by Institutional
Review Boards (IRBs) at each participating site and at
each site housing investigators (a total of eight IRBs).
EBQI Intervention
We described the steps, or phases, in the TIDES EBQI
process and their cost in prior publications [19]. These
include: preparation (leadership engagement); design
(developing a basic design at the regional level and
engaging local practices); and implementation (Plan-Do-
Study-Act or PDSA cycles to refine CCM until it
becomes stable as part of routine care). The randomized
trial reported here began during the early implementa-
tion phase of TIDES.
During preparation (approximately 2001 and 2002),
each region learned about the project and identified its
regional leadership team. During the design phase, the
regional leadership team and representatives from some
local sites carried out a modified Delphi panel [8,22] to
set CCM design features. For example, two out of three
regions chose primarily telephone-based rather than in-
person care management [23], reflecting concern for
providing mental health access to rural veterans. The
remaining region switched to this approach after initial
PDSA cycles.
The implementation phase began with enrollment of
the first patient in a PDSA cycle. After the depression
care manager (DCM) was designated or hired, she and
a single PCC initially worked together to plan and
implement rapid enlarging PDSA cycles that aimed to
test the referral process, safety, process of depression
care, and outcomes. Cycles began with one patient and
one clinician in each participating practice. After sev-
eral cycles (e.g., 10 to 15 patients) care managers
began engaging additional clinicians and patients
through academic detailing and local seminars [24,25].
A total of 485 patients had entered CCM by June 2003
prior to the start of the randomized trial. Thus, in all
practices, the EBQI-designed CCM model was part of
routine care before recruitment for the randomized
evaluation began [19]. When randomized trial enroll-
ment began, care manager workloads were in equili-
brium, with similar numbers of patients entering and
exiting CCM. During and after the trial improvement
work continued, with for instance a focus on care
manager electronic decision support, training, and
methods for engaging primary care providers, but at a
gradual pace.
PDSA cycles require aims, measures, and feedback.
Initial aims focused on successful development of pro-
gram components. For example, for decision support,
PDSA cycles assessed questions such as: Is the DCM’s
initial assessment capturing information necessary for
treatment planning? Are DCMs activating patients [26]?
How usable is EBQI-CCM information technology for
consultation, assessment, and follow-up [27-29]? For
patient safety, cycles asked: Is there a working suicide
risk management protocol in place [30]? Later cycles
focused on how to best publicize the intervention and
educate staff and how to best manage more complicated
patients through collaboration with mental health spe-
cialists [31,32]. Throughout all cycles, DCMs monitored
patient process of care and outcomes.
In terms of measures, we rigorously trained DCMs to
administer instruments (e.g., the PHQ-9) and keep
registries of patient process and outcomes. Registry
data provided measures for overarching quarterly
PDSA cycles focused on patient enrollment (e.g.,
patients referred versus enrolled), patient process of
care (e.g., treatments, location of care in primary care
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outcomes.
PDSA cycles involved feedback to participants. Inter-
disciplinary workgroups were the major forum for shar-
ing and discussing PDSA results [31]. In the care
management and patient self-management support
workgroup, care managers met weekly for an hour by
phone. Lead mental health specialists and lead PCCs
met monthly in the collaborative care workgroup, while
regional leaders (administrative, mental health, and pri-
mary care) met quarterly in the senior leader work-
group. Study team members assisted in administratively
supporting the workgroups, reviewing cycle results, and
supporting improvement design.
The study team fed back results for quarterly site-level
PDSAs on patient process and outcomes to care man-
agers, primary care, mental health, and administrative
leaders at practice, medical center, and Veteran’sI n t e -
grated Service Network (VISN) levels. Quarterly reports
were formatted like laboratory tests, with a graph of
patient outcome results; an example report is included
in a previous publication [11].
Randomized evaluation sample
Researchers created a database of potential patient eva-
luation participants from CCM and non-CCM practices
using VA electronic medical records. Inclusion criteria
were having at least one primary care appointment in
the preceding 12 months in a participating practice, and
having one pending appointment scheduled within the
three months post-selection (n = 28, 474). Exclusion cri-
teria were having conditions that required urgent care
(acute suicidality, psychosis), inability to communicate
over the telephone, or prior naturalistic referral by the
patient’s PCC to the DCM.
Data collection
Trained interviewers from California Survey Research
Services Inc. (CSRS) screened eligible patients for
depression or dysthymia symptoms between June 2003
and June 2004 using the first two questions of the
PHQ-9 [33] by telephone interview. Interviewers admi-
nistered the balance of the PHQ-9 to screen positive
patients, and enrolled those with probable major depres-
sion based on a PHQ-9 score of 10 or above. Inter-
viewers referred eligible and consenting evaluation
patients to the appropriate DCM for treatment. Evalua-
tion patients were re-surveyed by CSRS at seven months
post-enrollment, between March 2004 and February
2005. Health Insurance Portability and Accountability
Act (HIPAA) rules introduced during the study required
changes in the consent process for administrative data
analysis: we re-consented willing patients at the seven-
month survey.
Depression Care Management Protocol
Both patients naturalistically referred to CCM prior to
and during the study and patients referred to CCM as
part of the randomized evaluation were followed by
DCMs according to the TIDES care manager protocol.
The protocol, developed by participating experts and
sites, defined patients who had probable major depres-
sion (defined as an initial PHQ-9 greater than or equal
to 10) as eligible for six months of DCM panel manage-
ment. Patients with subthreshold depression (an initial
PHQ-9 between five and nine) who also had a) a prior
history of depression, or b) dysthymia were also eligible.
Patients who entered into mental health specialty care
c o u l db ed i s c h a r g e df r o mt h ep a n e la f t e rt h ei n i t i a l
assessment and any needed follow-up to ensure success-
ful referral. All others were to receive at least four care
manager follow-up calls that included patient self-man-
agement support and PHQ-9 measurement. All panel-
eligible patients were to be called and re-assessed by the
DCM at six months. The protocol specified that any
patient not eligible for or who discontinued care man-
agement be referred back to the primary care provider
with individualized resource and management
suggestions.
Power Calculations
Design power calculations indicated that to detect a 50%
improvement in anti-depressant prescribing assuming an
intra-class correlation coefficient (ICC) of 0.01, and nine
sites, with 46 patients per site, the study would have
about 81% power using a two-sided 5% significance
level. To allow for 20% attrition, 56 patients needed to
be enrolled from each site. During data collection, new
studies indicated the assumed ICC might have been too
small, so within budgetary limitations, the sampling
from CCM practices was increased to 386 and non-
CCM practices to 375. Post-power calculations showed
that the actual ICC was 0.028 and the within-group
standard deviation 6.25, suggesting there was adequate
power (0.96) to detect a 20% difference in anti-depres-
sant prescribing between the two study arms, but not
enough power (0.45) to detect a 10% difference. Power
calculations for detecting a difference in depression
symptom improvement across the two study arms show
a posteriori power to detect a 20% difference between
the two study arms of between 0.21 and 0.29.
Survey and administrative data measures
Our primary study outcome measure, and the basis for
our power calculations, was receipt of appropriate treat-
ment, a process of care goal that requires less power
than that required to demonstrate symptom outcome
improvement. Previous studies [5] had demonstrated
process/outcome links [34] for collaborative care with
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and quality of life improvements. For this QI study, we
therefore aimed at a sample suitable for showing process
change. We evaluated depression symptoms using the
PHQ-9 [33] and quality of life changes using SF36V2
[35]. We also assessed physical and emotional healthcare
satisfaction [36]. For evaluation patients whose consent
allowed us access to their electronic medical records, we
constructed adherence measures based on VA adminis-
trative databases. For these patients, we measured anti-
depressant availability fro mt h eV AP h a r m a c yB e n e f i t s
Management and mental health specialty visits from
VA’s Outpatient Care file. We used two measures:
whether a patient had any antidepressant fill at appro-
priate dosage in the seven-month time period, and the
medication possession ratio (MPR) [37]. The MPR is
defined as the proportion of days that patients had anti-
depressants in hand during the seven-month time per-
iod. We defined receipt of appropriate treatment as
either having an antidepressant fill at or above mini-
mum therapeutic dosage and achieving an MPR of 0.8
or having four or more mental health specialty visits
[38].
Our covariate measures included baseline measures of
depression symptoms, functioning, satisfaction, and
adherence as described above, as well as other variables
hypothesized to affect outcomes. These included dysthy-
mia [39], history of medications for bipolar disorder,
anxiety [38], post-traumatic stress disorder (PTSD) [40],
alcohol use [41], and medical co-morbidity [42]. Alter-
natively, we used a slightly modified version of the
Depression Prognostic Index (DPI) [43].
Evaluation of impacts of clinician early adopter status as
a contextual factor
Data collection
We trained DCMs to collect registry information on
all patients referred to them and used it to prepare
quarterly reports to regional and site managers. DCMs
entered data, including PHQ-9 results, on each patient
referred to them (including those referred by research
interviewers) into a Microsoft Excel-based depression
registry. Care managers recorded, de-identified, and
then transmitted registry data. DCMs transmitted data
on 974 patients between the date of the first PDSA
cycle and the end date of the randomized evaluation.
Recorded data included whether the patient had been
naturalistically referred or referred as part of the ran-
domized evaluation, and indicated the patient’s PCC,
but no patient personal health information identifiers
such as age. The project statistician replaced clinician
names with assigned study codes that linked clinicians
to practice site only, without additional information.
Care manager registry-based measures
We used the number of naturalistic referrals (i.e., those
carried out as part of routine care outside of the rando-
mized evaluation) recorded in the registry for each PCC
to characterize PCC adopter status [20]. We categorized
these clinicians into four groups, based on number of
referrals to CCM. We designated clinicians who never
chose to refer outside of the randomized evaluation as
having a low predilection to adopt the model (no refer-
rals). We classified clinicians with one to four referrals
as CCM slow adopters, and over five referrals as CCM
early adopters. We classified clinicians who had chosen
to make more than ten referrals as habitual CCM users.
These cut-points reflect the distribution of the variable
as well as the clinical judgment that five referrals pro-
vide substantial experience and ten referrals indicates
that referral has become the PCC’s routine.
We used the registry results to identify both rando-
mized evaluation and naturalistically referred patients
eligible for panel management per the TIDES care man-
ager protocol. We also defined adequate care manager
follow-up of panel-eligible patients based on the TIDES
DCM protocol for follow-up, such that, for example, a
patient who required four DCM follow-up visits was
judged as having adequate care if the registry reported
four DCM visits during which a PHQ-9 was
administered.
Data analysis
Randomized evaluation
We weighted all analyses to control for potential enroll-
ment bias based on age and gender using administrative
data on the approached population [34,44]. We
weighted the analyses for attrition on baseline depres-
sion symptoms and functional status. We adjusted for
possible clustering of data by site within region. Statisti-
cal analyses used STATA 10.0 [45] and SPSS 15.0 [46].
We also controlled for variation in elapsed time from
baseline to follow-up surveys by including a variable
indicating the number of days between the baseline and
follow-up surveys.
We compared patient characteristics in CCM and
non-CCM practices using t-tests for continuous vari-
ables and chi-square tests for categorical variables. For
multivariate outcome analyses, we used generalized esti-
mating equations (GEE) to assess the impact of CCM
intervention at seven months after the baseline with
repeated measures at the patient level, two records per
person (pre- and post-intervention periods) [47]. The
effect of the intervention was assessed by the interaction
term of the indicator of post-time period and the indica-
tor of the intervention group. We did not conduct
three-level analyses that treated region as a blocking
Chaney et al. Implementation Science 2011, 6:121
http://www.implementationscience.com/content/6/1/121
Page 5 of 15factor and examined CCM at the site level because we
had only one usual care site per region. For continuous
dependent variables (such as PHQ-9 score), we used the
GEE model with the normal distribution and an identity
link function. For dichotomous dependent variables
(such as the indicator of adequate dosage of antidepres-
sant use), we use the GEE model with a binomial distri-
bution and a logit link function. For all the GEE models,
we used the exchangeable correlation option to account
for the correlation at the patient and clinic level. We
compared CCM to non-CCM patient outcomes using
two analytical models. In the first model, we included
all covariates as individual variables. In the second
model, we included only the DPI. Because the results
were similar, we used the DPI model.
Care manager registry analysis
We used chi-square to assess the relationships between
provider referral type and adequate care manager fol-
low-up. We used one-way ANOVA to assess PHQ-9 dif-
ference scores with Scheffe post-hoc comparisons to
show which level of follow-up by DCMs had the stron-
gest relationships with PHQ-9 outcomes.
Results
Figure 1 shows patient enrollment in the randomized
evaluation. 10, 929 primary care patients were screened
for depression, with 1, 313 patients scoring 10 or more
on the PHQ-9. A total of 761 completed the baseline
survey and, of those, 72% (546) completed the seven-
month survey. Of those completing the follow-up sur-
vey, 93% (506) consented to have their VA administra-
tive data used for research purposes.
Table 1 compares enrolled EBQI-CCM and non
EBQI-CCM site patients at baseline and shows no sig-
nificant differences. Completers of the seven-month sur-
vey were not significantly different from non-completers
on any of these baseline patient characteristics.
Table 2 shows the depression treatment and patient
outcome results across all patients enrolled in the ran-
domized evaluation at seven months. EBQI-CCM site
patients were significantly more likely to have an ade-
q u a t ed o s a g eo fa n t i d e p r e s s ant prescribed than were
non-EBQI-CCM patients (65.7% for EBQI-CCM versus
43.4% for non-EBQI CCM, p < 0.01). They were also
significantly more likely to have filled an antidepressant
prescription (MPR > 0). Completion of full appropriate
care within the seven-month follow-up period, however,
either through completion of appropriate antidepres-
sants or psychotherapy, was not different between the
groups. There was also no significant EBQI-CCM/non
EBQI-CCM difference in terms of depression symptoms,
functioning, or satisfaction with care. In exploratory
multivariable regression results predicting seven-month
PHQ-9 scores, EBQI-CCM also showed no significant
effect on symptom outcomes. Significant predictors of
seven-month PHQ-9 scores were the DPI prognostic
index, baseline PHQ-9, and VA administrative region.
Effects of context: adherence to CMM protocols among
randomized evaluation patients
Evaluation of adherence to CCM protocols showed
delays in contacting and initiating treatment among
patients referred by the study. Care managers initiated
patient contact an average of 47 days after referral
among randomized evaluation patients, and initiated
treatment an average of 16 days after first contact (not
shown).
Figure 2 shows that among the 386 randomized eva-
luation patients referred for care management, 241
(62%) had an initial clinical assessment by the DCM and
145 (38%) did not. Among the 241 patients assessed,
230 (95%) were eligible for care manager panel manage-
ment per protocol, while 11(5%) were referred back to
the primary care clinician with management suggestions
only because they had PHQ-9s less than ten, no prior
history of depression and no dysthymia. Among the 230
eligible for panel management, 187 (81%) completed the
six month care manager assessment. Overall, consider-
ing the entire group of referred patients, 232 (60%) did
not receive adequate care manager follow-up per the
TIDES protocol. In addition to the 145 patients without
an initial DCM clinical assessment, 87 (36%) of the 241
eligible patients did not receive adequate care manager
follow-up (not shown).
Effects of context: EBQI
All regions and target practices carried out priority set-
ting followed by PDSA cycles and design and implemen-
tation of CCM. CCM as implemented included all
aspects of the Chronic Illness Care model [48], including:
redesign (hiring and training of a care manager); infor-
mation technology (electronic consult and note tracking)
[27-29]; education and decision support (care manager
registries, standardized electronic assessment and follow-
up notes, clinician pocket cards, educational sessions,
academic detailing) [24,25]; collaboration with mental
health specialty for education, emergencies, and care
manager supervision [31]; identification of community
and local resources; and patient self-management sup-
port. More detailed results can be found elsewhere
[11,19]. Regions and practices varied, however, in the
extent of leadership, staff, and clinician involvement [49].
Effects of context: clinician adopter status
Table 3 shows the effects of clinician adopter status on
patient completion of adequate care manager follow-up
within the randomized evaluation. The patients in this
table include the 241 randomized evaluation patients
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baseline (Figure 2).
Among the 241, 71% (41 of 58) of patients of CCM
habitual users (making 10 or more referrals), 78% (42 of
54) of patients of CCM early adopters (making 5 to 9
referrals), 64% (36 of 56) of patients of CCM slow adop-
ters, and 48% (35 of 73) of patients of clinicians with a
low predilection to adopt CCM, received adequate care
manager follow-up (p = 0.003). Results were similar if
we conducted the analyses on the full population of 386
7 CCM Practices
14,862 Patient Telephone 
Numbers Collected 
5,602 Patients screened for depression 
x 5,013 Sampling criteria 
met: Telephone numbers 
not used 
x 699 Unreachable:
  Maximum call attempts   
x 3,154 Refused
x 669 Ineligible*
x 3,080 Sampling criteria 
met: Telephone numbers 
not used 
x 645 Unreachable:
  Maximum call attempts   
x 3,485 Refused
x 800 Ineligible*
3 Non-CCM Practices
13,612 Patient Telephone 
Numbers Collected 
5,327 Patients screened for depression 
10 VA Primary Care 
Practices Randomized 
689 Patients eligible: PHQ-9 >10  624 Patients eligible: PHQ-9 >10 
x 288 Refused enrollment 
after taking PHQ-9 
x 15 Acutely Suicidal 
x 235 Refused enrollment 
after taking PHQ-9 
x 14 Acutely Suicidal 
386 Completed Baseline Survey   375 Completed Baseline Survey 
x 32 Non-working/wrong 
telephone numbers 
x 19 Unreachable: 
Maximum call attempts 
x 4 Deceased  
x 7 Too ill 
x 36 Refused 7 Month 
Survey 
x 40 Non-working/wrong 
telephone numbers 
x 29 Unreachable: 
Maximum call attempts 
x 6 Deceased  
x 7 Too ill 
x 35 Refused 7 Month 
Survey 
288 Complete PAQ-7 Month Survey 
x 20 Did not give consent to 
use administrative data 
258 Complete PAQ-7 Month Survey 
x 20 Did not give consent to 
use administrative data 
268 Complete PAQ-7 Month Survey and had 
Administrative Data 
238 Complete PAQ-7 Month Survey and had 
Administrative Data
*Ineligible at baseline refers to those who were deceased, too ill, institutionalized, or had cognitive, 
language or hearing problems 
Figure 1 Sampling flow chart.
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EBQI-CCM sites
Baseline patient characteristics EBQI-CCM
(N = 288)
Non EBQI-CCM
(N = 258)
P-value
Age-mean (SD) 64.0 (12.4) 64.4 (12.7) 0.73
% Male (gender) 95.8 96.5 0.62
% white 86.2 88.1 0.53
% married 63.9 63.9 0.99
Education 0.36
% < high school 11.5 14.6
% high school or more 88.5 85.4
Employment 0.81
% Working 14.8 14.1
% not working/on disability/retired/other 85.2 85.9
Region
% A 32.5 34.6 0.63
% B 36.2 34.7 0.72
% C 31.2 30.7 0.90
Seattle comorbidity index
41 7.50 (3.3) 7.65 (3.4) 0.61
% 3 chronic conditions or more 16.6 12.7 0.22
% Current PTSD 50.9 49.1 0.62
Alcohol use (AUDIT_C)
0 57.6 54.1 0.70
1 to 3 22.5 23.3
4 to 12 19.9 22.5
% ≥2 VA mental health visits (past 6 months) 27.0 26.3 0.85
% Poor health status 46.9 41.0 0.19
% Satisfied or very satisfied w/mental health care 62.4 67.2 0.27
Total social support - mean (SD) 2.27 (1.2) 2.32 (1.7) 0.64
Adjusted for population weights. N.S. = not significant at p < 0.05 level. Total social support - lower is more supportive
Table 2 Depression treatment and outcomes comparing EBQI-CCM site patients with non EBQI-CCM site patients at
baseline and seven months
Baseline Seven months
EBQI-
CCM
Non EBQI-
CCM
Difference EBQI-
CCM
Non EBQI-
CCM
Difference
Clinical care (administrative data) (N = 268) (N = 238) (N = 268) (N = 238)
Adequate dosage of antidepressant prescribed within 7 months post
baseline (%)
49.6 41.5 8.1* 65.7 43.4 22.3**
Medication possession ratio > 0 (%) 52 43 9 67 45 22*
Completion of appropriate care (MPR > 0.8 or completion of 4+
therapy visits) (%)
38.0 34.9 3.1 47.1 41.9 5.2
Symptoms and functioning (survey data) (N = 288) (N = 258) (N = 288) (N = 258)
Depression symptom severity (mean PHQ-9 score)
†(SD) 15.5 (4.4) 15.7 (4.7) -0.2 11.5 (6.5) 11.6 (6.7) -0.1
Patients below threshold for major depression (% PHQ-9 < 10) 0 0 0 39.9 41.4 -1.5
Physical functional status (mean SF-12 role physical score)
†† (SD) 29.2 (36.2) 34.8 (40.7) -5.6* 32.6 (39.4) 34.1 (35.6) -1.5
Emotional functional status (mean SF-12 role emotional score)
†† (SD) 47.1 (41.4) 50.0 (41.8) -2.9 49.9 (49.3) 50.0 (41.5) -0.1
Satisfaction with Mental Health Care (% somewhat or very satisfied)
†† 67.2 62.4 4.8 69.1 71.2 -2.1
Means, SDs and percentages are unadjusted. Analyses were weighted for enrollment bias and attrition.
*=p<0 . 0 5
** = p < 0.01
† Lower score is better
†† Higher score is better.
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Page 8 of 15randomized evaluation patients referred to care manage-
ment, and assigned those not reached by DCMs as not
receiving adequate follow-up (p = 0.03 for the parallel
comparison), or if we restricted the analyses to the 230
of 241 randomized evaluation patients who were eligible
for panel management based on a baseline PHQ-9 by
the DCM that showed probable major depression (p =
0.01).
Effects of Context: Adherence to protocol among
randomized evaluation versus naturalistically referred
patients
Figure 2 suggests that EBQI-CCM was used differently
under naturalistic provider-referred than under rando-
mized evaluation-referred conditions, including differ-
ences in delays and rates of completion for baseline
DCM assessment, types of patients referred and rates of
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 VA Primary Care CCM 
Practices   
590 Patients Naturalistically 
Referred to Depression Care 
Manager (DCM)  
285 Eligible for DCM Panel Management Per Protocol 
 
230 Eligible for DCM Panel Management Per Protocol 
193 Completed DCM 6 Month Assessment  187 Completed DCM 6 Month Assessment 
119 were not assessed by the DCM 
  80 Unable to Contact 
  17 Refused 
  1 Cancelled by PCP 
  4 followed in MH Specialty Clinic 
  2 Already in Research Cohort 
  5 Too Impaired, 1 Died 
  9 No Data 
 
 
145 were not assessed by the DCM 
  34 Unable to Contact 
  12 Refused 
  63 Followed in MH Specialty 
Clinic  
  1 Too Impaired 
  35 No Data 
92  did not complete final 6 month DCM 
follow-up assessment  
 
  69 declined follow-up or could not be 
reached  
  20 lost during DCM turnover 
 3 Died 
43 did not complete final 6 month 
DCM follow-up assessment 
  
  38 declined or could not be reached 
  3 lost during DCM turnover 
  2 Died 
386 Patients Referred by 
Research Protocol to 
Depression Care Manager 
380 Patients Total Completed DCM 6 Month Assessment 
471 were assessed by the 
DCM 
  46 did not need DCM 
panel management per 
protocol 
  14 refused panel 
management 
  20 couldn’t be reached 
after multiple attempts 
  3 died  
  103 dropped out (unclear 
why) 
  6 No data 
241 were assessed by the 
DCM 
  11 did not need DCM 
panel management per 
protocol (PHQ-9 <10, 
no prior history, not 
dysthymic) 
Figure 2 Naturalistic and evaluation-enrolled collaborative care patient flow chart.
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Page 9 of 15completion of the DCM six month follow-up assess-
ment. Among 976 total patients (randomized evaluation
plus naturalistically referred) entered into the care man-
ager registry preceding and during the evaluation enroll-
ment period, 386 (40%) were referred through the
randomized evaluation process and 590 (60%) were
referred naturalistically. Among the 386 randomized
evaluation-based referrals, 62% (241) completed a base-
line assessment. Among the 590 naturalistic referrals,
80% (471) completed a baseline DCM assessment (p <
0.001 for differences in assessment). Compared to the
average elapsed time of 47 days from referral to care
managers’ patient contact initiation for randomized eva-
luation patients, naturalistic referrals were contacted in
an average of 15 days (p < 0.001 for differences in
delays). Once assessed by the DCM, a greater propor-
tion of randomized evaluation than of naturalistically
referred patients were assessed as eligible for DCM
panel management (230 of 241, or 95% of randomized
evaluation patients compared to 285 of 471, or 61% of
naturalistically referred patients (p < .0001 for differ-
ences in eligibility). Once enrolled in panel management
randomized evaluation patients were more likely to
complete the six month DCM follow-up assessment.
Among the 230 randomized evaluation patients eligible
for panel management, 187 (81%) completed a six
month care manager assessment. Among the 285 natur-
alistically referred patients who were eligible for panel
management, 193 (68%) completed a six month care
manager assessment (p < .0005 for differences in six
month assessments).
We found that CCM offered as a voluntary referral
service to PCCs was heavily used by some clinicians and
rarely used by others (not shown). Naturalistically
referred patients came predominantly from early adop-
ters and habitual users, while research-referred, rando-
mized evaluation-enrolled patients reflected the full
distribution of clinician adopter levels. For example,
among the 386 randomized evaluation-enrolled patients
referred for care management, 27.2% came from clini-
cians who had referred 10 or more patients to CCM
(habitual users). Among 590 naturalistically referred
patients, 72.5% came from clinicians who were habitual
users of CCM (p < 0.001).
Finally, we assessed the relationship between depres-
sion symptom outcomes and adequate depression care
manager follow-up. We found that 24-week PHQ-9 out-
comes were significantly better among patients in EBQI-
CCM practices (randomized evaluation referred and nat-
uralistically referred patients combined) who received
adequate care manager follow-up than among those
who did not based on bivariate regression analysis with
PHQ-9 change as the dependent variable (p = 0.001). As
shown in Table 4, this result appears to reflect a dose
response pattern for care manager visits, with the largest
difference being between those with just baseline and
24-week follow-up visits and those with four or more
visits (p < 0.001).
Discussion
This study aimed to determine whether healthcare orga-
nizations could improve depression care quality using
Table 3 Early adopter clinician effects on adequacy of care manager follow-up in EBQI-CCM sites
Patients’ primary care clinicians’ history of early adoption of
collaborative care management (CCM)
EBQI-CCM site patients enrolled in the randomized evaluation and
recorded in the care manager quality improvement registry*, **
(N = 241)
Patient received adequate
care manager follow-up
Patient did not receive adequate
care manager follow-up
Total
N (%) N (%) N
(%)
Evaluation-enrolled patients of 21 EBQI-CCM site clinicians with low
predilection to adopt CCM (made no referrals)
(34.4% of study clinicians)
35 (47.9) 38 (52.1) 73
(100)
Evaluation-enrolled patients of 17 EBQI-CCM slow CCM adopter
clinicians (made 1 to 4 referrals) (27.9% of study clinicians)
36 (64.3) 20 (35.7) 56
(100)
Evaluation-enrolled patients of 11 early CCM adopter clinicians (made
5 to 9 referrals) (18.0% of study clinicians)
42 (77.8) 12 (22.2) 54
(100)
Evaluation-enrolled patients of 12 habitual user clinicians (made 10 or
more referrals) (19.7% of study clinicians)
41 (70.7) 17 (29.3) 58
(100)
Total (evaluation-enrolled patients of all 61 clinicians) 154 (63.9) 87 (36.1) 241
(100)
*The quality improvement registry includes both a) patients enrolled in the randomized evaluation and referred to CCM by researchers and b) naturalistically
referred patients. The registry records all visits for patients experiencing CCM. Only patients enrolled in the randomized evaluation who also are listed in the
registry (and thus have data on CCM visits) are included in these analyses.
** p = 0.003 comparing adequate care manager follow-up by type of clinician, with the difference between clinicians with low predilection to adopt CCM and all
others showing the greatest difference (Scheffe test)
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Page 10 of 15EBQI for adapting CCM to local and organizational
context [8-11]. This multi-level research/clinical partner-
ship approach called for systematic adaptation of pre-
viously-tested, effective CCM for depression [4-7], and
for focusing on the key aspects of the Chronic Illness
Care Model (i.e., patient self-management support, deci-
sion support, delivery system design, and clinical infor-
mation systems) [48]. Researchers served as technical
experts rather than decision makers or implementers.
To rigorously and formatively evaluate EBQI-CCM early
in its life cycle in VA, we used cluster randomized trial
methodology powered to detect changes in the process,
but not outcomes, of care. Our answer regarding
whether healthcare organizations can use EBQI methods
to improve depression care is mixed in that EBQI-CCM
showed improvements in process (antidepressant use)
while not demonstrating outcome improvements.
Unlike our answer regarding the effectiveness of
EBQI-CCM, our answer regarding the usefulness of ran-
domized trials for formative evaluation is strongly posi-
tive. The trial was relatively inexpensive ($750, 000)
relative to system costs for fully implementing CCM
nationally; identified the need to improve the EBQI-
CCM model; and provided critical information on how
to improve it. Information on issues raised by this trial,
such as care manager workload, follow-up, access, and
clinician effects on patient outcomes, is essential if the
results of over 35 CCM randomized trials are to be
replicated in routine care.
To understand study results, we evaluated adherence
to the study intervention plans. In this study, the inves-
tigators implemented EBQI, rather than CCM itself;
engaged sites implemented CCM. In terms of overall
adherence to EBQI methods, our approach engaged
regional and local leaders effectively in guiding local QI
teams through PDSA cycles for designing and imple-
menting CCM. All participating practices implemented
and maintained EBQI-CCM throughout the study. In
terms of adherence to CCM, as implemented by regio-
nal and local leaders with EBQI support, QI data [11]
showed that EBQI-CCM incorporated the key features
identified in the published CCM literature [50] in terms
of patient education and activation [26,51], care
management follow-up, systematically assessed symp-
toms, and collaboration between primary care providers,
care managers, and mental health specialists [31,32].
Adherence to the TIDES DCM protocol for promptness
and completion of all required clinical assessments for
individual randomized evaluation patients, however, was
problematic.
Despite the identified problems with completion of
assessments, the EBQI-CCM site patients were pre-
scribed antidepressants at appropriate doses significantly
m o r eo f t e nt h a nt h o s ei nn o nE B Q I - C C Mp r a c t i c e s( a
23% difference). EBQI-CCM site patients similarly had
significantly more prescriptions actually filled (a 22% dif-
ference). Prior studies of CQI or lower-intensity EBQI
for depression in primary care have not shown
improved prescribing [8,14,15]. Increased antidepressant
use, however, did not translate into robust improve-
ments in depression symptoms, functional status, or
satisfaction with care in intent to treat analyses.
Because we aimed for the most efficient use of study
resources for evaluating the process and effectiveness of
an implementation method, rather than the effectiveness
of CCM, we predicated our design on the lower sample
size required for assessing a key process of care (antide-
pressant use) rather than the more demanding sample
size needed for assessing effects on patient symptom
outcomes. Our power to detect a 20% difference in
depression symptoms was only between 0.21 and 0.29,
based on the obtained sample size and ICC. We thus
cannot definitively say that depression symptom out-
comes did not improve within the timeframe studied.
We were, however, disappointed in the lack of robust
symptom impacts, and sought to determine more expli-
citly what lessons readers should take away from our
work.
To place our findings in context, we first asked: Do
our randomized evaluation results test the effectiveness
of CCM as a model? We conclude they do not. Other
CCM studies have tested the CCM model as implemen-
ted using designs with higher researcher control, and
shown effectiveness in diverse healthcare sites [4-7].
These studies, however, did not test self-implementation
of CCM by healthcare practices or sites using QI
Table 4 Number of depression care manager visits versus change in patient PHQ-9 depression scores
Depression care manager visits during which a PHQ-9 was administered** PHQ-9 score mean change
(lower is better)
95% confidence intervals
(a) Baseline and 24 week only (2 total) (n = 95) -3.83 -5.10, -2.56
(b) Baseline, 24 week, and one additional (3 total) (n = 120) -6.94 -8.09, -5.79
(c) Baseline, 24 week, and two to four additional (4 to 6 total) (n = 163) -8.45 -9.49, -7.41
Based on Care Manager Quality Improvement Registry Data. Total n = 378 representing those clinician- and research-referred patients finishing panel
management (380, Fig. 2) minus two clinician-referred patients who completed the 24 week DCM follow-up visit but did not have a 24 week DCM PHQ-9
recorded. Significance levels are p < 0.001 comparing the PHQ-9 change for group (a) to group (c); p = 0.003 comparing group (a) to group (b); and p = 0.16
comparing group (b) to group (c).
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Page 11 of 15methods. For example, meta-analyses on the effective-
ness of the CCM model [4-6] exclude prior studies of
QI methods for implementing CCM [8,14,15], recogniz-
ing that these studies address a different question. Our
randomized evaluation results test the ability of health-
care organizations and sites to adapt and implement
research-designed CCM as a part of their organizational
cultures and structures. In so doing, the results provide
information for improvement. Because typical healthcare
organizations or practices must use QI methods to
adopt research-based depression care models, the chal-
lenges faced by this study are likely to be relevant to
managers, policymakers, and researchers interested in
improving depression care at a system or organizational
level.
Our goal of combing a randomized evaluation with QI
methods resulted in challenges related to timing. Our
fixed windows for baseline and follow-up surveys meant
that delays in initiation of care management for study
patients, followed by lags in PCC ordering of treatments,
were not accommodated in assessing outcomes. Thus,
for many patients, antidepressant treatment or psy-
chotherapy began only a short time before the seven-
month follow-up survey. Furthermore, while 81% of ran-
domized evaluation patients eligible for panel manage-
ment completed the six month DCM assessment, many
fewer had completed the designated number of follow-
up contacts by that time. These results highlight the
challenges for researchers in timing outcome measures
relative to patient access to CCM in a study with a rig-
orous randomized design but low researcher control of
the intervention.
Excessive demand for care management proved to be
another challenge, and one that is potentially relevant to
CCM program managers. While we did not intend to
overload care managers, we inadvertently did. As origin-
ally envisioned, the randomized evaluation would have
begun after EBQI-CCM practices had completed a small
number of PDSA cycles of the CCM intervention invol-
ving as few as ten and no more than fifty total patients.
Under this scenario, care managers could have covered
both naturalistic referrals and randomized evaluation
referrals, given typical care manger caseloads [52]. In
reality, the requirements of eight separate IRBs, faced
with an unfamiliar implementation research model and
with the introduction of HIPAA [53], led to a prolonged
period between start of naturalistic PDSA intervention
development and start of the randomized evaluation (a
gap per intervention practice of between 111 and 334
days with a mean of 263 days). The study team discov-
ered that it was not feasible, under QI conditions, to
turn off naturalistic referrals. Thus, care manager case-
loads were full with naturalistically referred patients
prior to the start of the randomized evaluation.
Our study mimicked a potential organizational policy
such that patients screening positive for depression
would be automatically referred to CCM, along with
patients referred by their PCCs. This scenario represents
a potentially realistic policy in VA in particular, because
routine depression screening is already mandated. Our
results show that implementing effective follow-up of
primary care-detected depression for all eligible patients
will be challenging.
Few previous studies of CCM have tested reach [54]
or the degree to which all eligible individuals in a given
clinical setting can have access to the CCM model.
Most previous CCM randomized trials have limited
total patient access to CCM to patients enrolled in the
trial, thus artificially controlling demand. Care manager
caseload capacity [52] bounds effective reach under nat-
uralistic conditions. Our study ratio of approximately
one care manager per 10, 000 primary care patients may
need to be adjusted or ameliorated by other depression
care redesigns.
Looking within the randomized evaluation and its
patients, we found unanticipated associations between
patient outcomes and whether the PCC they belonged
to was an early adopter of CCM. Patients referred to
CCM by the study team, but whose PCC was an early
CCM adopter [20], were significantly more likely to be
assessed by care managers and to receive adequate care
manager follow-up than other patients, independent of
patient depression severity or comorbidities. These
results suggest that patient access to full CCM care was
shaped more by who their provider was than by patient
need.
We think the clinician effects we observed are likely to
substantially affect CCM models under naturalistic con-
ditions. Clinician effects did not influence patient enroll-
ment in the study. No clinicians in these practices
refused to have their patients referred to CCM by study
personnel, and the proportions of randomized evalua-
tion patients belonging to early adopter clinicians versus
those with a low predilection to adopt the model mir-
rored the proportions of clinicians who fell into these
categories in the study practices.
Clinician predisposition to adopt CCM affects use of
the model under naturalistic conditions in another way
as well. In essence, patients of early adopter clinicians
tend to monopolize the DCM resource. For example,
73% of naturalistically referred patients belonged to clin-
icians who habitually used CCM (ten or more naturalis-
tic referrals), while only 27% of randomized evaluation
patients belonged to this type of clinician. Registry data
on patients naturalistically referred to CCM shows the
same pattern we saw in data from the randomized eva-
luation; the quality of CCM care is better among
patients of early adopter clinicians [11]. Differential use
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Page 12 of 15of and benefits from CCM resources based on clinician
characteristics should be taken into account both in
interpreting studies of CCM and in implementing CCM
as routine care.
Theories of social justice and mental health parity
would argue that patient need, rather than clinician
characteristics, should govern access to clinical
resources. Our results emphasize the importance of
active PCC engagement in CCM, a topic not addressed
in most prior CCM research, though identified as issue
by prior qualitative work on the TIDES program [49].
Clinician effects may be mediated by, for example, more
effective encouragement to patients about participating,
and greater promptness in responding to care manager
suggestions about ordering treatment. These activities
might in turn be moderated by differences in clinician
knowledge and attitudes about depression and/or
greater experience in using CCM. Monitoring of clini-
cian effects on use of CCM (and potentially other men-
tal health services) is critical for CCM programs, and
better methods for bringing all clinicians in line with
the early adopters are needed [55].
There are reasons to collect program evaluation data
other than testing program efficacy or effectiveness. We
think CCM programs should monitor patient outcomes
using a registry, as was done in this study, for purposes
of monitoring program utility and safety. Unlike our
randomized evaluation results, our pre-post care man-
ager registry data reflects how the program functions
naturalistically. These naturalistic data, while not testing
model effectiveness, show that CCM as implemented in
these VA sites performed safely, and with outcomes that
met or exceeded CCM targets for patients whose clini-
cians chose to refer them.
We used our registry data as well as our randomized
trial data to shape and improve EBQI-CCM. As reported
elsewhere [11,19], registry results on naturalistically
referred patients show that: 82% of 208 were treated for
depression in primary care without specialty referral;
74% stayed on medication for the recommended time;
and 90% of primary care managed patients and 50% of
mental health specialty managed patients had clinically
significant reductions in depressive symptomatology
(PHQ-9 scores < 10) at six months. On average, PHQ-9
scores improved nine points; improvement remained
significant controlling for depression severity and com-
plexity. While subject to selection bias, these results
showed potential benefit of the program for diverse
patients. If the results had been different, such as show-
ing little or no symptom improvement or raising safety
concerns, we would have considered stopping or fully
redesigning the program. Instead, our follow-up PDSA
cycles focused on reducing patient and clinician
selection effects while continuing to monitor patient
outcomes.
Our comparison of registry data with rigorous study
data is encouraging regarding the validity of registry
data for depression program monitoring purposes.
Although we would not have discovered the effects of
clinician adopter status based on registry data, because
of the few included patients belonging to low adopter
clinicians, we can replicate this clinician effect in retro-
spect through the registry. Other major context effects
demonstrated by the randomized experiment, including
effects of patient complexity, can also be observed
through the registry data, supporting its validity. Per
protocol analysis (looking only at patients who received
full CCM) of symptom and functional status outcomes
for randomized evaluation patients was consistent with
registry results in terms of the level of outcome
improvement observed, providing qualitative triangula-
tion on the importance of ensuring patient completion
of CCM as a critical target for improvement. We con-
clude that registry data on patient care and symptom
outcomes can be accurate enough for program monitor-
ing, with appropriate attention to selection bias and care
manager training on data collection.
Registry data has limitations in addition to its inability
to provide fully representative data. We know that regis-
try patients were selected and not representative of all
eligible patients. In addition, care managers, though
extensively trained, may have been less objective or con-
sistent in their administration of the PHQ-9 than were
external data collectors.
One of the explicit goals of the TIDES program was to
develop a CCM model that could be spread nationally in
VA [56]. In terms of this goal, the randomized evalua-
tion of EBQI reported here informed the ongoing QI
and model spread process for TIDES. For example, the
issues with differential PCC involvement led to systema-
tic training and engagement approaches on a national
basis [56]. As it improved, the TIDES program became
one of the bases for the Veterans Health Administration
(VHA) Primary Care-Mental Health Integration(PC-
MHI) initiative [57-59] and is codified in the VHA’s
Uniform Mental Health Services Package directive [60].
EBQI thus seems to be an effective method for design-
ing a program that sustains and spreads. Data from the
randomized evaluation reported here, however, indicate
that ensuring that the sustained, spread programs pro-
duced by EBQI achieve comparative effectiveness on a
population basis is also critical. Ongoing national eva-
luation of primary care-mental health integration in VA
has the potential to achieve this goal.
This study has limitations. The study focused on a
single healthcare system (the VA), and on non-
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third of which were rural [21]. Results may not be gen-
eralizable to other systems or practice types. Second,
our study’s power to detect symptom outcomes was lim-
ited by our follow-up window of seven months. For
some patients, delays in access to care managers and
thus in treatment initiation may have limited the possi-
bilities for completing treatment within the study win-
dow. Third, we were not able to confirm registry data
on care manager visits by analysis of administrative data
b e c a u s eas p e c i f i ce n c o u n t e rc o d ef o rd e p r e s s i o nc a r e
management was not introduced by the VA until after
this study. Fourth, use of consecutive sampling over-
represents more frequent users of primary care relative
to the full population of visiting patients [61]. Finally,
our process evaluation subgroup analyses on early adop-
ters are not appropriate for drawing conclusions about
causality or the overall effectiveness of EBQI-CCM.
Selection bias, in particular, cannot be eliminated as a
factor in these analyses.
In summary, this study showed that CCM, as imple-
mented using EBQI, improved antidepressant prescrib-
ing across a representative sample of patients attending
study practices. While this randomized evaluation does
not test the effectiveness of CCM as an ideal model, it
does test the effectiveness of CCM as designed and
implemented in VA using QI methods, albeit early in
the program’s lifespan. The study encountered a number
of difficulties likely to apply to other healthcare organi-
zations implementing CCM as routine care, including
the consequences of care manager overload and of dif-
ferential PCC adoption of CCM. The lack of robust
patient symptom improvement for the experimental
group compared to usual care points to the importance
of continuously monitoring and improving CCM pro-
grams during and after implementation. Otherwise, the
cost-effectiveness benefits promised by CCM studies will
not be achieved in reality.
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